7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)- cyclopentyl]-N-ethyl-hept-5-enamide (bimatoprost) in crystalline form II, methods for preparation, and methods for use thereof

Details for Australian Patent Application No. 2010321831 (hide)

Owner Allergan, Inc.

Inventors Ambrus, Gyorgy F.; Karami, Kiomars; Wu, Ke

Agent Davies Collison Cave

Pub. Number AU-A-2010321831

PCT Pub. Number WO2011/063276

Priority 61/263,471 23.11.09 US

Filing date 19 November 2010

Wipo publication date 26 May 2011

International Classifications

C07C 405/00 Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins

A61K 31/5575

A61P 27/06 Drugs for disorders of the senses

Event Publications

21 June 2012 PCT application entered the National Phase

  PCT publication WO2011/063276 Priority application(s): WO2011/063276

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010321832-Anti-Orai1 antigen binding proteins and uses thereof

2010321830-Suppression of cancer metastasis